Gland Pharma Limited (NSE:GLAND) — Stock Price

Rs2667.30 INR
▲ 2.55% today

Gland Pharma Limited (NSE:GLAND) is currently trading at Rs2667.30 INR, up 2.55% today. Over the past 52 weeks, shares have ranged between Rs1596.80 and Rs2667.30. This page tracks Gland Pharma Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see GLAND market cap overview.

Gland Pharma Limited (GLAND) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Gland Pharma Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Gland Pharma Limited Income Statement — Revenue, Profit & Earnings by Year

Gland Pharma Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs64.31 Billion Rs56.17 Billion Rs56.65 Billion Rs36.25 Billion Rs44.01 Billion
Cost of Revenue Rs44.98 Billion Rs24.62 Billion Rs25.54 Billion Rs18.59 Billion Rs22.49 Billion
Gross Profit Rs19.32 Billion Rs31.54 Billion Rs31.11 Billion Rs17.65 Billion Rs21.51 Billion
Research & Development Rs2.23 Billion Rs1.92 Billion Rs1.95 Billion Rs2.01 Billion Rs2.27 Billion
SG&A — Rs1.14 Billion Rs1.32 Billion Rs485.32 Million Rs313.62 Million
Total Operating Expenses Rs7.26 Billion Rs14.17 Billion Rs12.88 Billion Rs6.08 Billion Rs5.67 Billion
Operating Income Rs12.06 Billion Rs17.38 Billion Rs18.23 Billion Rs11.57 Billion Rs15.84 Billion
EBITDA Rs16.30 Billion Rs12.31 Billion Rs12.97 Billion Rs10.31 Billion Rs15.10 Billion
EBIT Rs12.06 Billion Rs8.72 Billion Rs9.71 Billion Rs8.84 Billion Rs14.00 Billion
Interest Expense Rs332.79 Million Rs239.87 Million Rs262.00 Million Rs74.47 Million Rs52.42 Million
Income Before Tax Rs14.65 Billion Rs10.63 Billion Rs11.33 Billion Rs10.55 Billion Rs16.19 Billion
Income Tax Expense Rs4.37 Billion Rs3.64 Billion Rs3.60 Billion Rs2.74 Billion Rs4.07 Billion
Net Income Rs10.27 Billion Rs6.99 Billion Rs7.72 Billion Rs7.81 Billion Rs12.12 Billion

Gland Pharma Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Gland Pharma Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs125.11 Billion Rs112.25 Billion Rs106.61 Billion Rs87.78 Billion Rs78.34 Billion
Total Current Assets Rs75.27 Billion Rs67.83 Billion Rs56.45 Billion Rs69.01 Billion Rs58.52 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs737.41 Million Rs3.96 Billion Rs15.82 Billion Rs18.54 Billion Rs29.27 Billion
Net Receivables Rs18.91 Billion Rs15.17 Billion Rs16.48 Billion Rs10.36 Billion Rs12.93 Billion
Inventory Rs17.44 Billion Rs16.85 Billion Rs16.76 Billion Rs19.78 Billion Rs12.29 Billion
Property, Plant & Equipment — — — — Rs16.80 Billion
Goodwill Rs2.94 Billion Rs2.48 Billion Rs2.42 Billion Rs0.00 —
Total Liabilities Rs21.53 Billion Rs20.74 Billion Rs19.37 Billion Rs8.19 Billion Rs6.76 Billion
Total Current Liabilities Rs16.08 Billion Rs15.65 Billion Rs13.98 Billion Rs7.29 Billion Rs5.82 Billion
Long-term Debt Rs699.25 Million Rs776.64 Million Rs1.07 Billion Rs32.61 Million Rs38.21 Million
Net Debt Rs-30.76 Billion Rs-22.42 Billion Rs150.78 Million Rs-19.04 Billion Rs-3.11 Billion
Total Stockholder Equity Rs103.58 Billion Rs91.51 Billion Rs87.24 Billion Rs79.59 Billion Rs71.58 Billion
Retained Earnings — Rs71.57 Billion Rs67.88 Billion Rs60.15 Billion Rs52.34 Billion

Gland Pharma Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Gland Pharma Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs12.31 Billion Rs9.15 Billion Rs9.97 Billion Rs3.64 Billion Rs7.91 Billion
Capital Expenditures Rs4.91 Billion Rs3.85 Billion Rs3.90 Billion Rs2.23 Billion Rs5.22 Billion
Free Cash Flow Rs7.41 Billion Rs5.30 Billion Rs6.07 Billion Rs1.41 Billion Rs2.69 Billion
Investing Cash Flow Rs-945.34 Million Rs17.05 Billion Rs-17.57 Billion Rs12.08 Billion Rs-10.03 Billion
Financing Cash Flow Rs-3.85 Billion Rs-4.33 Billion Rs-7.99 Billion Rs149.19 Million Rs348.98 Million
Dividends Paid Rs2.97 Billion Rs3.29 Billion — — —
Stock-Based Compensation Rs454.68 Million Rs0.00 — Rs0.00 Rs46.21 Million
Depreciation Rs4.24 Billion Rs3.78 Billion Rs3.45 Billion Rs1.47 Billion Rs1.10 Billion
Change in Cash Rs8.03 Billion Rs21.99 Billion Rs-15.52 Billion Rs15.90 Billion Rs-1.74 Billion

Gland Pharma Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Gland Pharma Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 05, 2026 — 16.39 —
May 15, 2026 22.23 15.78 +40.87%
Jan 28, 2026 16.98 14.39 +18.00%
Nov 03, 2025 11.15 12.97 -14.03%
Aug 05, 2025 13.33 13.28 +0.38%
May 20, 2025 11.32 14.13 -19.89%
Feb 03, 2025 12.42 12.17 +2.05%
Nov 04, 2024 9.93 10.92 -9.07%